• What type and form exists and when to consider using multiparticulate systems
  • The main advantages of multiparticulate systems for oral drug delivery, such as controlled and targeted drug release, fixed dose combinations, enhanced bioavailability, dosage flexibility and others
  • How these systems can help solve challenges of orally delivered drugs, such as uniformity, stability, manufacturing complexity and patient compliance

The webinar will provide case studies illustrating applications of multiparticulate systems and will conclude with a Q&A session, providing an opportunity for attendees to engage with experts in the field.

Who should attend:

  • Pharmaceutical and biopharmaceutical companies looking to enhance their oral drug delivery processes
  • Individuals working in formulation development
  • Pharmaceutical and biopharmaceutical companies with products transitioning from discovery to clinical development or in clinical development
  • Pharma/biopharma/biotech companies with small molecules drug candidates or small molecules in development.

About the speaker

Ramesh Muttavarapu, MSc, MBA – Technical and Scientific Affairs, Thermo Fisher Scientific, Inc.

Ramesh has more than 20 years of experience in developing and commercialising oral solid dosage forms. His expertise includes formulating dosage forms with mini tablets with tailored drug release profiles and multiparticulates and he has developed and commercialised a variety of products and is co-inventor of a patent on delayed release pellets.
He holds a Bachelors and Masters in pharmaceutics from the University of Bangalore and University of Annamalai, India, respectively. He, he earned an MBA from Linder College of Business, University of Cincinnati, OH, USA.